Showing 961 - 980 results of 226,558 for search '(( 10 ((nn decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (we decrease)) ))', query time: 1.59s Refine Results
  1. 961
  2. 962
  3. 963

    Individual relationship between muscle lactate concentrations and PCr concentrations (expressed in percent of initial value) (2A) and between PCr decreases (expressed in percent of initial value) and muscle IMP concentrations (2B), during 10REP (open circles), and 5REP (filled circles). by Esteban M. Gorostiaga (316019)

    Published 2013
    “…<p>Individual relationship between muscle lactate concentrations and PCr concentrations (expressed in percent of initial value) (2A) and between PCr decreases (expressed in percent of initial value) and muscle IMP concentrations (2B), during 10REP (open circles), and 5REP (filled circles).…”
  4. 964

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  5. 965

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  6. 966

    Pre-match open aortic group. by Tomi Obafemi (12328433)

    Published 2023
    “…However, the incidence of post-op ventilator associated pneumonia (VAP) decreased from 5.0% to 2.1% (p = 0.003) and post-op urinary tract infections (UTIs) from 8.3% to 3.6% (p<0.001). …”
  7. 967
  8. 968

    Fig 10 - by Jie He (132999)

    Published 2024
  9. 969
  10. 970
  11. 971
  12. 972
  13. 973

    Non-Steady-State Fickian Diffusion Models Decrease the Estimated Gel Layer Diffusion Coefficient Uncertainty for Diffusive Gradients in Thin-Films Passive Samplers by Samuel D. Hodges (16412358)

    Published 2023
    “…A finite difference model (FDM) developed based on Fick’s second law with non-steady-state (N-SS) flux decreased uncertainty in <i>D</i><sub>Gel</sub> tenfold. …”
  14. 974
  15. 975
  16. 976
  17. 977
  18. 978

    Propensity-score matched open aortic group. by Tomi Obafemi (12328433)

    Published 2023
    “…However, the incidence of post-op ventilator associated pneumonia (VAP) decreased from 5.0% to 2.1% (p = 0.003) and post-op urinary tract infections (UTIs) from 8.3% to 3.6% (p<0.001). …”
  19. 979

    Pre-match CABG/Valve group. by Tomi Obafemi (12328433)

    Published 2023
    “…However, the incidence of post-op ventilator associated pneumonia (VAP) decreased from 5.0% to 2.1% (p = 0.003) and post-op urinary tract infections (UTIs) from 8.3% to 3.6% (p<0.001). …”
  20. 980

    Propensity-score matched CABG/Valve group. by Tomi Obafemi (12328433)

    Published 2023
    “…However, the incidence of post-op ventilator associated pneumonia (VAP) decreased from 5.0% to 2.1% (p = 0.003) and post-op urinary tract infections (UTIs) from 8.3% to 3.6% (p<0.001). …”